- The report assesses Anxiety Disorders therapeutics based on drug target, mechanism of action( MoA), route of administration( RoA) and molecule type- The report summarizes all the dormant and discontinued pipeline projects- The report reviews latest news related to pipeline therapeutics for Anxiety Disorders
Reasons To Buy- Gain strategically significant competitor information, analysis, and insights to formulate effective R & D strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Identify and understand important and diverse types of therapeutics under development for Anxiety Disorders- Identify potential new clients or partners in the target demographic- Develop strategic initiatives by understanding the focus areas of leading companies- Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics- Devise corrective measures for pipeline projects by understanding Anxiety Disorders pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Buy a Sample Copy of This Report @ http:// www. radiantinsights. com / research / anxiety-disorders-pipelinereview-h2-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 7 List of Figures 9 Introduction 10 Global Markets Direct Report Coverage 10 Anxiety Disorders Overview 11 Therapeutics Development 12 Pipeline Products for Anxiety Disorders- Overview 12 Pipeline Products for Anxiety Disorders- Comparative Analysis 13 Anxiety Disorders- Therapeutics under Development by Companies 14 Anxiety Disorders- Therapeutics under Investigation by Universities / Institutes 18 Anxiety Disorders- Pipeline Products Glance 19 Late Stage Products 19 Clinical Stage Products 20 Early Stage Products 21 Unknown Stage Products 22 Anxiety Disorders- Products under Development by Companies 23 Anxiety Disorders- Products under Investigation by Universities / Institutes 29 Anxiety Disorders- Companies Involved in Therapeutics Development 30 AbbVie Inc 30 Ache Laboratorios Farmaceuticos S / A 31 Adamed Sp. z o. o. 32 Addex Therapeutics Ltd 33 Amorsa Therapeutics Inc. 34 Avineuro Pharmaceuticals, Inc. 35 Azevan Pharmaceuticals, Inc. 36 Biohaven Pharmaceutical Holding Company Limited 37 Bionomics Limited 38 Boehringer Ingelheim GmbH 39